The status of lymph node involvement is a major component of the TNM staging system. The
N categories for lung cancer have remained unchanged since the fourth edition of the TNM …

Simple Summary Preoperative mediastinal staging plays a crucial role in determining the
appropriate treatment strategy for patients with stage IIIA-N2 disease, but an optimal …

Objective There are few studies evaluating whether to proceed with planned resection when
a patient with non–small cell lung cancer (NSCLC) unexpectedly is found to have N2 …

Objective Conversion to lobectomy is typically performed when positive lymph nodes are
found during intentional segmentectomy. Our objective was to evaluate survival after …

Background In case of suspicious lymph nodes on computed tomography (CT) or
fluorodeoxyglucose positron emission tomography (FDG-PET), advanced tumour size or …

Preoperative mediastinal staging is crucial in the management of patients with non-small
cell lung cancer (NSCLC), especially to define prognosis and the most proper treatment. To …

Background The aim of this study was to evaluate the results of video-assisted
mediastinoscopic lymphadenectomy (VAMLA) for staging of non-small cell lung cancer …

The selection of patients for surgical intervention in the setting of N2 nodal disease remains
controversial with differences between centres, regions and continents. In an effort to …

The purpose of this article is to provide an update on evidence-based methods for
mediastinal staging in patients with lung cancer. This is a review of the recently published …

Objectives Invasive mediastinal staging is advised by guidelines in patients with resectable
non-small cell lung cancer (NSCLC) and suspicious lymph nodes (cN1-3) or for central, FDG …